Treatment of acute myocardial infarction

American Journal of Geriatric Cardiology

Volumn 10, Issue 6, 2001, Pages 328-336

  Rich, M W ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ALTEPLASE; ANTITHROMBOCYTIC AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST; GLYCERYL TRINITRATE; HEPARIN; MAGNESIUM; METOPROLOL; RETEPLASE; STREPTOKINASE; TICLOPIDINE; TIROFIBAN; VERAPAMIL;

ACUTE HEART INFARCTION; AGED; BLOOD CLOT LYSIS; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EVIDENCE BASED MEDICINE; HEART MUSCLE REPERFUSION; HUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; RANDOMIZED CONTROLLED TRIAL; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; UNITED STATES;

EID: 0034765069     PISSN: 10767460     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1076-7460.2001.00642.x     Document Type: Conference Paper

References (48)

1. The impact of age on the incidence and prognosis of acute myocardial infarction. The Worcester Heart Attack Study
2. Age and outcome with contemporary thrombolytic therapy: Results from the GUSTO-1 trial
3. Trends in acute myocardial infarction and coronary heart disease death in the United States
4. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17, 187 cases of suspected acute myocardial infarction: ISIS-2
5. Effect of intravenous APSAC on mortality after acute myocardial infarction: Preliminary report of a placebo-controlled clinical trial
6. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction
7. A prospective trial of intravenous streptokinase in acute myocardial infarction (ISAM). Mortality, morbidity, and infarct size at 21 days
8. Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET)
9. Indications for fibrinolytic therapy in suspected acute myocardial infarction: Collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients
10. Thrombolytic therapy in older patients
11. Lack of benefit for intravenous thrombolysis in patients with myocardial infarction who are older than 75 years
12. ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction)
13. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction
14. A comparison of reteplase with alteplase for acute myocardial infarction
15. Intracranial hemorrhage associated with thrombolytic therapy for elderly patients with acute myocardial infarction: Results from the Cooperative Cardiovascular Project
16. Primary angioplasty for acute myocardial infarction in the elderly
17. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction
18. Effect of age on outcome with primary angioplasty versus thrombolysis
19. Primary coronary angioplasty vs. thrombolysis for the management of acute myocardial infarction in elderly patients
20. Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the US from 1990 through 1999. The National Registry of Myocardial Infarction 1, 2 and 3
21. Relation between hospital primary angioplasty volume and mortality for patients with acute MI treated with primary angioplasty vs. thrombolytic therapy
22. A comparison of thrombolytic therapy with primary coronary angioplasty for acute myocardial infarction
23. Early revascularization in acute myocardial infarction complicated by cardiogenic shock
24. 1999 Update: ACC/AHA Guidelines for the Management of Patients with Acute Myocardial Infarction: Executive summary and recommendations. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction)
25. Use and effectiveness of intravenous heparin therapy for treatment of acute myocardial infarction in the elderly
26. Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11 B trial
27. A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q Wave Coronary Events Study Group
28. A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes
29. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty
30. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization
31. Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes
32. A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina
33. Inhibition of the platelet glycoprotein Ilb/IIIa receptor with tirofiban in unstable angina, and non-Q wave myocardial infarction
34. Platelet glycoprotein IIb/IIIa receptor antagonists and their use in elderly patients
35. Doubleblind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting: The Clopidogrel Aspirin Stent International Cooperative Study (CLASSICS)
36. Randomized evaluation of anticoagulation versus antiplatelet therapy after coronary stent implantation in high-risk patients: The multicenter aspirin and ticlopidine trial after intracoronary stenting (MATTIS)
37. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment evaluation
38. Randomised trial of intravenous atenolol among 16,027 cases of suspected acute myocardial infarction: ISIS-1
39. Metoprolol in acute myocardial infarction (MIAMI) A randomised placebo-controlled international trial
40. Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomised trial
41. Immediate vs. deferred β-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) II-B Study
42. GISSI-3: Effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction
43. ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction
44. The effect of the angiotensin-converting enzyme inhibitor zofenopril on mortality
45. Significance of nitroglycerin-induced hypotension with inferior wall acute myocardial infarction
46. Glucose-insulin-potassium therapy for treatment of acute myocardial infarction: An overview of randomized placebo-controlled trials